Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Stine Brændegaard Winther, Gábor Liposits, Halla Skúladóttir, et al.
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 5, pp. 376-388
Closed Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients with Solid Cancers: Protocol for a Danish prospective cohort study (PROGNOSIS-G8)
Helena Møgelbjerg Ditzel, Ann-Kristine Weber Giger, Cecilia Margareta Lund, et al.
Journal of Geriatric Oncology (2021) Vol. 12, Iss. 8, pp. 1270-1276
Open Access | Times Cited: 8
How best to treat older patients with metastatic colorectal cancer?
Julien Taı̈eb
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 5, pp. 331-333
Open Access | Times Cited: 8
Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study
Gábor Liposits, Jesper Ryg, Halla Skúladóttir, et al.
Journal of Geriatric Oncology (2022) Vol. 14, Iss. 1, pp. 101408-101408
Open Access | Times Cited: 5
Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly
Chikara Kunisaki, Sho Sato, Nobuhiro Tsuchiya, et al.
European Surgical Research (2021) Vol. 62, Iss. 1, pp. 40-52
Open Access | Times Cited: 6
Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
Dave E. W. van der Kruijssen, Auke J. S. van der Kuil, Geraldine R. Vink, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 7, pp. 1360-1369
Open Access | Times Cited: 4
High‐throughput method to analyze tegafur and 5‐fluorouracil in human tears and plasma using hydrophilic interaction liquid chromatography/tandem mass spectrometry
Ritsuko Shiokawa, Xiao‐Pen Lee, Miho Yamada, et al.
Rapid Communications in Mass Spectrometry (2019) Vol. 33, Iss. 24, pp. 1906-1914
Closed Access | Times Cited: 5
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper
Nicolò Matteo Luca Battisti, Gábor Liposits, Nienke A. de Glas, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 10
Closed Access | Times Cited: 5
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study
Gerardo Rosati, Domenico Corsi, Antonio Avallone, et al.
Journal of Geriatric Oncology (2021) Vol. 13, Iss. 3, pp. 302-307
Closed Access | Times Cited: 5
Danish translation and validation of the Geriatric 8 and the modified Geriatric 8 screening tools
Helena Møgelbjerg Ditzel, Ann-Kristine Weber Giger, Agon Olloni, et al.
Journal of Geriatric Oncology (2022) Vol. 13, Iss. 8, pp. 1268-1272
Open Access | Times Cited: 3
Palliative medical cancer treatment of the elderly
Stine Brændegaard Winther, Gábor Liposits, Trine Lembrecht Jørgensen, et al.
Ugeskrift for Læger (2024) Vol. 186, pp. 1-8
Open Access
Low-dose chemotherapy combined with delayed immunotherapy in the neoadjuvant treatment of non-small cell lung cancer and dynamic monitoring of the drug response in peripheral blood
Chaoyang Liang, Qi Song, Wenhao Zhou, et al.
(2024)
Open Access
Low-dose chemotherapy combined with delayed immunotherapy in the neoadjuvant treatment of non-small cell lung cancer and dynamic monitoring of the drug response in peripheral blood
Chaoyang Liang, Qi Song, Wenhao Zhou, et al.
(2024)
Open Access
Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy? A prospective real-world observational study
Ingunn Hatlevoll, Are Kristensen, Tora S. Solheim, et al.
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 3, pp. 101715-101715
Open Access
Treatment optimization of fluoropyrimidine-based chemotherapy
Jonathan Emanuel Knikman
(2024)
Open Access
Effect of comprehensive geriatric assessment on hospitalizations in older adults with frailty initiating curatively intended oncologic treatment: The PROGNOSIS-RCT study
Ann-Kristine Weber Giger, Helena Møgelbjerg Ditzel, Marianne Ewertz, et al.
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 7, pp. 101821-101821
Closed Access
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
Pilar García‐Alfonso, Elena Élez, Javier Soto-Alsar, et al.
ESMO Open (2024) Vol. 9, Iss. 12, pp. 103986-103986
Closed Access
Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer—a study in AIO oncologists
M Büttelmann, Ralf‐Dieter Hofheinz, Anke Kröcher, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100761-100761
Open Access | Times Cited: 1
Variations in colorectal cancer pattern of care by age and comorbidity in South Australia
Kazzem Gheybi, Elizabeth Buckley, Agnès Vitry, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12118-12127
Open Access | Times Cited: 1
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)
Louise Skau Rasmussen, Stine Brændegaard Winther, Inna M. Chen, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)
Louise Skau Rasmussen, Stine Brændegaard Winther, Inna M. Chen, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
A study on metabolic characteristics and metabolic markers of gastrointestinal tumors
Shan Cong, Shanshan Bai, Minghao Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The impact of timely cancer diagnosis on age disparities in colon cancer survival in New Zealand
Sophie Pilleron, Camille Maringe, Hadrien Charvat, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Outcomes following potentially curative therapies for older patients with metastatic colorectal cancer
Ifigenia Konstantinou, Iestyn M. Shapey, Demetris Papamichael, et al.
European Journal of Surgical Oncology (2020) Vol. 47, Iss. 3, pp. 591-596
Closed Access | Times Cited: 1
Capecitabine in combination with panitumumab is not the treatment of choice in older patients with metastatic colorectal cancer
Gábor Liposits, Per Pfeiffer
Journal of Geriatric Oncology (2021) Vol. 13, Iss. 1, pp. 114-115
Closed Access | Times Cited: 1
The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study
Gábor Liposits, Stine Brændegaard Winther, Jesper Ryg, et al.
Journal of Geriatric Oncology (2023) Vol. 15, Iss. 2, pp. 101632-101632
Open Access

Scroll to top